COH.AX - Cochlear Limited
| Previous close | 242.73 |
| Open | 241.45 |
| Bid | 240.71 x 10000 |
| Ask | 240.72 x 3400 |
| Day's range | 238.82 - 243.61 |
| 52-week range | 184.62 - 253.36 |
| Volume | |
| Avg. volume | 149,879 |
| Market cap | 15.953B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 60.94 |
| EPS (TTM) | 3.95 |
| Earnings date | 15 Aug 2023 - 16 Aug 2023 |
| Forward dividend & yield | 3.10 (1.28%) |
| Ex-dividend date | 21 Mar 2023 |
| 1y target est | 226.40 |
Simply Wall St.Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
- Simply Wall St.
Cochlear Limited's (ASX:COH) largest shareholders are retail investors with 55% ownership, institutions own 45%
Key Insights Significant control over Cochlear by retail investors implies that the general public has more power to...
- Simply Wall St.
Cochlear (ASX:COH) shareholders have earned a 12% CAGR over the last three years
You can receive the average market return by buying a low-cost index fund. But you can make better returns by buying...
- Simply Wall St.
As Cochlear Limited (ASX:COH) hits AU$16b market cap, insiders may be dismayed about not purchasing higher quantities
Last week, Cochlear Limited ( ASX:COH ) insiders, who had purchased shares in the previous 12 months were rewarded...
PR NewswireHearing loss in global spotlight as technology and research leaders collaborate to tackle rising impact, and experts unite to demystify care
According to the World Health Organization (WHO), the number of people living with hearing loss is set to reach 2.5 billion by 2050.1 Now, leading technology companies, researchers, and people living with hearing loss are coming together to tackle its rising impact.
PR NewswireCochlear announces 2023 winners of annual scholarships
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, announced today the winners of the 21st annual Graeme Clark, the 12th annual Anders Tjellström, and 1st annual Vocational Scholarships. The Academic Scholarships are named after two pioneers of the hearing implant industry and recognize Cochlear™ Nucleus® Implant, Cochlear Baha® System and Cochlear Osia® System recipients in the United States and Canada who uphold the Cochlear ideals of leadership, humanity, and dem
PR NewswireCochlear announces audio streaming from Amazon Fire TV devices for hearing implant users
Ahead of International Cochlear Implant Day (February 25, 2023), Cochlear is announcing that it will now offer Audio Streaming for Hearing Aids (ASHA) support on compatible Fire TV devices for people living with hearing implant technology. The advancement represents the first time that a smart TV device will stream sound directly to a hearing implant sound processor.
- Simply Wall St.
Do Fundamentals Have Any Role To Play In Driving Cochlear Limited's (ASX:COH) Stock Up Recently?
Cochlear's (ASX:COH) stock is up by 1.5% over the past three months. We wonder if and what role the company's...
- Simply Wall St.
Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...
- Simply Wall St.
Individual investors account for 52% of Cochlear Limited's (ASX:COH) ownership, while institutions account for 47%
Every investor in Cochlear Limited ( ASX:COH ) should be aware of the most powerful shareholder groups. With 52% stake...
- Simply Wall St.
Those who invested in Cochlear (ASX:COH) five years ago are up 21%
If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...
- Simply Wall St.
The Independent Non-Executive Chairman of the Board of Cochlear Limited (ASX:COH), Catriona Deans, Just Bought 13% More Shares
Even if it's not a huge purchase, we think it was good to see that Catriona Deans, the Independent Non-Executive...
PR NewswireFDA approves Cochlear's Nucleus 8 Sound Processor, smaller, smarter, better connected cochlear implant technology
Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, receives U.S. Food and Drug Administration (FDA) approval for the Cochlear™ Nucleus® 8 Sound Processor. The Nucleus 8 Sound Processor is now the smallest and lightest behind-the-ear cochlear implant sound processor available in the industry. 1-3 It is also the world's first cochlear implant sound processor ready to provide direct audio connectivity to everyday consumer electronics using the next generation LE Audio
- Simply Wall St.
Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)
How far off is Cochlear Limited ( ASX:COH ) from its intrinsic value? Using the most recent financial data, we'll take...
- Simply Wall St.
Cochlear (ASX:COH) Is Paying Out A Larger Dividend Than Last Year
The board of Cochlear Limited ( ASX:COH ) has announced that it will be paying its dividend of A$1.45 on the 17th of...
- Simply Wall St.
A Cochlear Limited (ASX:COH) insider increased their holdings by 40% last year
Insiders were net buyers of Cochlear Limited's ( ASX:COH ) stock during the past year. That is, insiders bought more...
- Simply Wall St.
Cochlear Limited's (ASX:COH) Stock Is Going Strong: Have Financials A Role To Play?
Cochlear (ASX:COH) has had a great run on the share market with its stock up by a significant 9.4% over the last month...
- Simply Wall St.
Returns On Capital At Cochlear (ASX:COH) Paint A Concerning Picture
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
- Simply Wall St.
What You Need To Know About Cochlear Limited's (ASX:COH) Investor Composition
A look at the shareholders of Cochlear Limited ( ASX:COH ) can tell us which group is most powerful. Generally...